CardioFocus, Inc.

Activity by year

20192020202120222023202420252026

Contract

May 30, 2021CONTRACTChina$20.0M
Grand Pharmaceutical Group licenses HeartLight X3 laser ablation platform from CardioFocus
Grand Pharmaceutical Group (远大医药) entered into an exclusive licensing agreement with CardioFocus to commercialize the HeartLight X3 laser ablation platform for atrial fibrillation in Greater China, with milestone payments up to $20 million.
Grand Pharmaceutical Group customer CardioFocus, Inc. supplier #Medical Devices beta.zhitongcaijing.com
Apr 29, 2019CONTRACTGardner, Massachusetts, United States$2.22M
Precision Optics receives $2.2 million order from CardioFocus for cardiovascular endoscope
Precision Optics Corporation has received a $2.2 million follow-on order from CardioFocus, Inc. to manufacture a cardiovascular endoscope for the HeartLight Endoscopic Ablation System. Deliveries are scheduled over two years starting April 2019.
Precision Optics Corporation supplier CardioFocus, Inc. customer #Medical Devices einpresswire.com

Customers

Suppliers

Loading…